Benzinga | Feb 5, 2021 07:07AM EST

EGENXBIO Announces Presentations At Angiogenesis, Exudation, And Degeneration 2021 Conference On Feb. 13

ROCKVILLE, Md., Feb. 5, 2021 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced that two oral presentations will be presented at the Angiogenesis, Exudation, and Degeneration 2021 conference taking place virtually from February 12 to 13, 2021.

The presentations will be as follows:

Presentation Title Subretinal Gene Therapy for Exudative AMD

Presenter Allen C. Ho, M.D., Director of Retina Research at Wills Eye Hospital and Mid Atlantic Retina

Date/Time Saturday, February 13, 2021, 9:15 a.m. ET

Presentation Title Suprachoroidal Gene Therapy for Exudative AMD and Diabetic Retinopathy

Presenter Peter A. Campochiaro, M.D., Director, Retinal Cell and Molecular Laboratory, Professor of Ophthalmology, The Wilmer Eye Institute, Johns Hopkins University School of Medicine

Date/Time Saturday, February 13, 2021, 9:45 a.m. ET